Reposted by David Smadja 🎗️
🚨 New paper from the lab in ATVB
Dexamethasone protects against COVID-19 endothelium-induced coagulopathy 🦠🔥🫁🩸
@davidmsmadja.bsky.social @hopitalpompidou.bsky.social @upcite.bsky.social @parcc-inserm.bsky.social
@ahajournals.bsky.social
@inserm.fr
www.ahajournals.org/doi/10.1161/...
ahajournals.org
Dexamethasone Suppresses Endotheliopathy and Endothelial-Induced Coagulopathy in COVID-19 | Arteriosclerosis, Thrombosis, and Vascular Biology
BACKGROUND: Endotheliopathy and coagulopathy are known complications of COVID-19, with a significant
association with mortality. Although dexamethasone is the standard of care for patients
with severe...